Positive-Feedback Regulation of Subchondral H-Type Vessel Formation by Chondrocyte Promotes Osteoarthritis Development in Mice

被引:133
作者
Lu, Jiansen [1 ,2 ]
Zhang, Haiyan [1 ]
Cai, Daozhang [1 ]
Zeng, Chun [1 ]
Lai, Pinglin [1 ]
Shao, Yan [1 ,2 ]
Fang, Hang [1 ]
Li, Delong [1 ,2 ]
Ouyang, Jiayao [1 ,2 ]
Zhao, Chang [1 ]
Xie, Denghui [1 ]
Huang, Bin [1 ]
Yang, Jian [3 ]
Jiang, Yu [4 ]
Bai, Xiaochun [1 ,2 ]
机构
[1] Southern Med Univ, Affiliated Hosp 3, Orthoped Hosp Guangdong Prov, Dept Orthoped,Acad Orthoped, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China
[3] Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Dept Biomed Engn, University Pk, PA 16802 USA
[4] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA
基金
中国国家自然科学基金;
关键词
OSTEOARTHRITIS; MTORC1; CHONDROCYTE; H-TYPE VESSELS; ANGIOGENESIS; ARTICULAR-CARTILAGE; ATTENUATES OSTEOARTHRITIS; VASCULAR-DISEASE; BONE; ANGIOGENESIS; MTOR; OSTEOGENESIS; PATHOGENESIS; HYPERTROPHY; INHIBITION;
D O I
10.1002/jbmr.3388
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Vascular-invasion-mediated interactions between activated articular chondrocytes and subchondral bone are essential for osteoarthritis (OA) development. Here, we determined the role of nutrient sensing mechanistic target of rapamycin complex 1 (mTORC1) signaling in the crosstalk across the bone cartilage interface and its regulatory mechanisms. Then mice with chondrocyte-specific mTORC1 activation (Tsc1 CKO and Tsc1 CKOER) or inhibition (Raptor CKOER) and their littermate controls were subjected to OA induced by destabilization of the medial meniscus (DMM) or not. DMM or Tsc1 CKO mice were treated with bevacizumab, a vascular endothelial growth factor (VEGF)-A antibody that blocks angiogenesis. Articular cartilage degeneration was evaluated using the Osteoarthritis Research Society International score. Immunostaining and Western blotting were conducted to detect H-type vessels and protein levels in mice. Primary chondrocytes from mutant mice and ADTC5 cells were treated with interleukin-1 beta to investigate the role of chondrocyte mTORC1 in VEGF-A secretion and in vitro vascular formation. Clearly, H-type vessels were increased in subchondral bone in DMM-induced OA and aged mice. Cartilage mTORC1 activation stimulated VEGF-A production in articular chondrocyte and H-type vessel formation in subchondral bone. Chondrocyte mTORC1 promoted OA partially through formation of VEGF-A-stimulated subchondral H-type vessels. In particular, vascular-derived nutrients activated chondrocyte mTORC1, and stimulated chondrocyte activation and production of VEGF, resulting in further angiogenesis in subchondral bone. Thus a positive-feedback regulation of H-type vessel formation in subchondral bone by articular chondrocyte nutrient-sensing mTORC1 signaling is essential for the pathogenesis and progression of OA. (C) 2018 American Society for Bone and Mineral Research
引用
收藏
页码:909 / 920
页数:12
相关论文
共 52 条
[1]
Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis [J].
Aaron, Roy K. ;
Dyke, Jonathan P. ;
Ciombor, Deborah McK. ;
Ballon, Douglas ;
Lee, Jonathan ;
Jung, Edward ;
Tung, Glenn A. .
SKELETAL BIOLOGY AND MEDICINE, PT B: DISEASE MECHANISMS AND THERAPEUTIC CHALLENGES, 2007, 1117 :124-137
[2]
Osteoarthritis: an update with relevance for clinical practice [J].
Bijlsma, Johannes W. J. ;
Berenbaum, Francis ;
Lafeber, Foris P. J. G. .
LANCET, 2011, 377 (9783) :2115-2126
[3]
Autophagy activation by rapamycin reduces severity of experimental osteoarthritis [J].
Carames, Beatriz ;
Hasegawa, Akihiko ;
Taniguchi, Noboru ;
Miyaki, Shigeru ;
Blanco, Francisco J. ;
Lotz, Martin .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (04) :575-581
[4]
Bone turnover and articular cartilage differences localized to subchondral cysts in knees with advanced osteoarthritis [J].
Chen, Y. ;
Wang, T. ;
Guan, M. ;
Zhao, W. ;
Leung, F-K-L. ;
Pan, H. ;
Cao, X. ;
Guo, X. E. ;
Lu, W. W. .
OSTEOARTHRITIS AND CARTILAGE, 2015, 23 (12) :2174-2183
[5]
Is progressive osteoarthritis an atheromatous vascular disease? [J].
Conaghan, PG ;
Vanharanta, H ;
Dieppe, PA .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) :1539-1541
[6]
Halofuginone attenuates osteoarthritis by inhibition of TGF- activity and H-type vessel formation in subchondral bone [J].
Cui, Zhuang ;
Crane, Janet ;
Xie, Hui ;
Jin, Xin ;
Zhen, Gehua ;
Li, Changjun ;
Xie, Liang ;
Wang, Long ;
Bian, Qin ;
Qiu, Tao ;
Wan, Mei ;
Xie, Min ;
Ding, Sheng ;
Yu, Bin ;
Cao, Xu .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) :1714-1721
[7]
Pathogenesis and management of pain in osteoarthritis [J].
Dieppe, PA ;
Lohmander, LS .
LANCET, 2005, 365 (9463) :965-973
[8]
Noninvasive methods of measuring bone blood perfusion [J].
Dyke, J. P. ;
Aaron, R. K. .
SKELETAL BIOLOGY AND MEDICINE, 2010, 1192 :95-102
[9]
Quality indicators for the primary care of osteoarthritis: a systematic review [J].
Edwards, J. J. ;
Khanna, M. ;
Jordan, K. P. ;
Jordan, J. L. ;
Bedson, J. ;
Dziedzic, K. S. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) :490-498
[10]
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression [J].
Elkin, M ;
Miao, HQ ;
Nagler, A ;
Aingorn, E ;
Reich, R ;
Hemo, I ;
Dou, HL ;
Pines, M ;
Vlodavsky, I .
FASEB JOURNAL, 2000, 14 (15) :2477-2485